Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
683 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- British Columbia Cancer Agency - Centre for the Southern Interior
Kelowna, British Columbia, Canada
- British Columbia Cancer Agency - Vancouver Cancer Centre
Vancouver, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Saint John Regional Hospital
Saint John, New Brunswick, Canada
- Margaret and Charles Juravinski Cancer Centre
Hamilton, Ontario, Canada
- Cancer Centre of Southeastern Ontario at Kingston General Hospital
Kingston, Ontario, Canada
- Grand River Regional Cancer Centre at Grand River Hospital
Kitchener, Ontario, Canada
- London Regional Cancer Program at London Health Sciences Centre
London, Ontario, Canada
- Southlake Regional Health Centre
Newmarket, Ontario, Canada
- R. S. Mclaughlin Durham Regional Cancer Centre at Lakeridge Health Oshawa
Oshawa, Ontario, Canada
- Ottawa Hospital Regional Cancer Centre - General Campus
Ottawa, Ontario, Canada
- St. Catharines General Hospital at Niagara Health System
Saint Catharines, Ontario, Canada
- Cancer Care Program at Thunder Bay Regional Health Sciences
Thunder Bay, Ontario, Canada
- Odette Cancer Centre at Sunnybrook
Toronto, Ontario, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
- St. Michael'S Hospital - Toronto
Toronto, Ontario, Canada
- Toronto East General Hospital
Toronto, Ontario, Canada
- Trillium Health Centre - Mississauga Site
Toronto, Ontario, Canada
- Windsor Regional Cancer Centre at Windsor Regional Hospital
Windsor, Ontario, Canada
- Allan Blair Cancer Centre at Pasqua Hospital
Regina, Saskatchewan, Canada
- Saskatoon Cancer Centre at the University of Saskatchewan
Saskatoon, Saskatchewan, Canada
- Providence Cancer Center at Providence Hospital
Mobile, Alabama, United States
- Alaska Regional Hospital Cancer Center
Anchorage, Alaska, United States
- Providence Cancer Center
Anchorage, Alaska, United States
- Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
Fort Smith, Arkansas, United States
- Nea Medical Center - Stadium Boulevard
Jonesboro, Arkansas, United States
- Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center
Burbank, California, United States
- East Bay Radiation Oncology Center
Castro Valley, California, United States
- Valley Medical Oncology Consultants - Castro Valley
Castro Valley, California, United States
- North Bay Cancer Center
Fairfield, California, United States
- Kaiser Permanente - Fremont
Fremont, California, United States
- Valley Medical Oncology
Fremont, California, United States
- Glendale Memorial Hospital Comprehensive Cancer Center
Glendale, California, United States
- California Cancer Care, Incorporated - Greenbrae
Greenbrae, California, United States
- Kaiser Permanente Medical Center - Hayward
Hayward, California, United States
- Veterans Affairs Medical Center - Loma Linda (pettis)
Loma Linda, California, United States
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- Contra Costa Regional Medical Center
Martinez, California, United States
- Tibotec Therapeutics - Division of Ortho Biotech Products, Lp
Marysville, California, United States
- Camino Medical Group - Treatment Center
Mountain View, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2005
- Primary completion
- 28 Feb 2015
- Completion
- 31 Jan 2018
- Last update posted
- 7 May 2020
- Registered enrollment
- 2,334
- Registry id
- NCT00265850
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.